M. Mello-Grand

发表

ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.

P. Ostano, A. Malek, R. García-Escudero, 2013, Cancer research.

ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer

A. Malek, C. Catapano, M. Mello-Grand, 2010, PloS one.

A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)

R. García-Escudero, S. Mapelli, C. Catapano, 2020, Cancers.

Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer

Alberto Costa, S. Marsoni, L. Villani, 2010, Breast Cancer Research and Treatment.

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma

P. Ostano, M. Mello-Grand, G. Chiorino, 2020, International journal of molecular sciences.

Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection

A. Naccarati, P. Ostano, A. Zitella, 2018, Carcinogenesis.

Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy

C. Ghimenti, M. Mello-Grand, G. Chiorino, 2012, Experimental and therapeutic medicine.

Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment.

C. Ghimenti, M. Mello-Grand, G. Chiorino, 2010, Experimental and therapeutic medicine.

A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers

G. Varani, Abhishek Mitra, S. Di Marco, 2017, Nature Communications.

1 ETS transcription factor ESE 1 / ELF 3 orchestrates a positive feedback loop that constitutively activates NF-B and drives prostate cancer progression

Giovanna, P. Ostano, A. Malek, 2013 .

Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties.

E. Turco, M. Mello-Grand, G. Chiorino, 2013, American journal of cancer research.

Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles

P. Ostano, D. Liscia, A. Di Leone, 2022, Human genomics.

Tumor and Stem Cell Biology ETS Transcription Factor ESE 1 / ELF 3 Orchestrates a Positive Feedback Loop That Constitutively Activates NFk B and Drives Prostate Cancer Progression

P. Ostano, A. Malek, R. García-Escudero, 2013 .

AKR1C3 is a biomarker and druggable target for oropharyngeal tumors

L. De Cecco, F. Perrone, P. Ostano, 2020, Cellular Oncology.

Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer

G. Dotto, K. Lefort, M. Mello-Grand, 2016, Oncotarget.

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.

S. Rossi, P. Ostano, A. Zitella, 2016, The Journal of clinical investigation.

ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.

C. Catapano, N. Longoni, M. Sarti, 2012, Cancer research.

Tumor and Stem Cell Biology ESE3/EHFControls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features

C. Catapano, N. Longoni, M. Sarti, 2012 .

Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells

Francesco Favero, Maurizio D'Incalci, F. Favero, 2010, PloS one.

lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study

D. Katsaros, E. Sartori, M. D’Incalci, 2016, Clinical Cancer Research.

Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation

P. Ostano, A. Brusco, A. Larionov, 2012, PloS one.

The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol

E. Petracci, P. Ostano, A. Ponti, 2017, BMC Cancer.

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

G. Migliardi, F. Montemurro, M. Aglietta, 2011, BMC Cancer.

Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

M. Colombo, C. Tripodo, P. Ostano, 2021, Cancer Research.

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA

S. Cristoni, D. Noonan, A. Albini, 2021, Frontiers in Oncology.

iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia

P. Ostano, B. Akgül, D. Bergamaschi, 2011, The EMBO journal.

Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression

C. Catapano, N. Longoni, M. Sarti, 2013, Oncogene.

The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression

R. Seiler, C. Catapano, L. Brino, 2012, Oncogene.

Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer

C. Catapano, M. Mello-Grand, G. Chiorino, 2008, Oncogene.

Differential angiogenesis of bone and muscle endothelium in aging and inflammatory processes

S. Bersini, M. Moretti, P. Ostano, 2023, Communications Biology.

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis

P. Provero, L. Silengo, F. Altruda, 2017, Nature Communications.

GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma *

L. Poliseno, D. Taverna, T. Venesio, 2021, The British journal of dermatology.

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis

P. Provero, L. Silengo, F. Altruda, 2017, Nature Communications.

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

G. Migliardi, F. Montemurro, M. Aglietta, 2011, BMC Cancer.

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

F. Montemurro, M. Aglietta, M. Mello-Grand, 2011, BMC Cancer.

ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.

P. Ostano, A. Malek, R. García-Escudero, 2013, Cancer research.